Viemed Healthcare Q3 revenue rises, but slightly misses estimates
VMD•Viemed Healthcare's third-quarter revenue rose 12% year over year to $80.67 million, slightly below the $80.78 million analyst estimate. The company raised the low end of its 2026 revenue outlook to $316 million and narrowed its adjusted EBITDA outlook to $64 million-$66 million.
1. Quarterly results
Viemed Healthcare reported third-quarter revenue of $80.67 million, up 12% year over year and slightly below the $80.78 million consensus estimate. Net income attributable to shareholders was $4.64 million, gross profit was $46.19 million and income from operations was $6.96 million.
2. 2026 outlook
The company expects 2026 revenue of $316 million to $320 million and adjusted EBITDA of $64 million to $66 million. It now sees net capital expenditures at 8.0% to 9.0% of revenue.
3. Growth drivers
Viemed attributed higher ventilator rental revenue to increased average patient volumes and reported strong growth in PAP therapy and sleep resupply patient counts. It said operating leverage and efficiency gains from earlier investments improved profitability.
